|
Re: Who Is Buying Those Pills?
|
1
|
Resverlogix Corp.
|
Jan 20, 2017 02:45PM
|
|
Resverlogix Provides Groundbreaking Results in Patients with Severe Kidney Impairments
|
1
|
Resverlogix Corp.
|
Jan 23, 2017 11:17AM
|
|
Re: NR
|
1
|
Resverlogix Corp.
|
Jan 23, 2017 11:19AM
|
|
Re: Resverlogix Provides Groundbreaking Results...
|
1
|
Resverlogix Corp.
|
Jan 23, 2017 11:22AM
|
|
biOasis Provides AGM Update – Expanding The biOasis Deal Flow Pipeline
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 23, 2017 11:30AM
|
|
Re: NR on phase 1 Kidney Trial
|
2
|
Resverlogix Corp.
|
Jan 23, 2017 11:45AM
|
|
Re: NR on phase 1 Kidney Trial
|
|
Resverlogix Corp.
|
Jan 23, 2017 12:08PM
|
|
Re: Merck's Verubecestat mechanisn of Action vs.RVX-208 & ZEN BET Inhibition Mechanism of action
|
7
|
Resverlogix Corp.
|
Jan 23, 2017 05:01PM
|
|
Phase 2 Kidney Trial
|
7
|
Resverlogix Corp.
|
Jan 24, 2017 04:52PM
|
|
Re: Phase 2 Kidney Trial
|
4
|
Resverlogix Corp.
|
Jan 24, 2017 05:09PM
|
|
Re: Keystone Symposia...
|
2
|
Resverlogix Corp.
|
Jan 25, 2017 06:22PM
|
|
Re: Keystone Symposia...
|
2
|
Resverlogix Corp.
|
Jan 26, 2017 09:38AM
|
|
Re: Resverlogix just tweeted this video...
|
1
|
Resverlogix Corp.
|
Jan 27, 2017 08:40AM
|
|
BBB-crossing shark antibody approach
|
|
BIOASIS TECHNOLOGIES INC
|
Jan 27, 2017 02:14PM
|
|
Re: BBB-crossing shark antibody approach
|
|
BIOASIS TECHNOLOGIES INC
|
Jan 29, 2017 09:47PM
|
|
Financials and MD&A on SEDAR
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jan 30, 2017 10:16PM
|
|
Re: It's Time For Zenith To Disclose
|
7
|
Zenith Epigenetics
|
Jan 31, 2017 10:01AM
|
|
Re: It's Time For Zenith To Disclose
|
3
|
Zenith Epigenetics
|
Jan 31, 2017 09:18PM
|
|
Keystone and Dialysis Conference
|
5
|
Resverlogix Corp.
|
Feb 01, 2017 04:36PM
|
|
Re: Clinical Trials
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 02, 2017 04:22PM
|
